Sodium Acetate

Sodium Acetate · SODIUM ACETATE ANHYDROUS 164 mg/mL · Injection, Solution, Concentrate · Intravenous · Amneal Pharmaceuticals Private Limited

NDC 80830-2435-02 · 25 BOTTLE, PLASTIC in 1 CARTON / 20 mL in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $88.80 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA218469
TE code: AP
Approval date: Aug 8, 2025
Patents / exclusivity: None on file

Shortage history

In shortage now — Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)Mar 23, 2016
month 126 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)Mar 23, 2016
month 126 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)Feb 3, 2016
month 128 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)Feb 3, 2016
month 128 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)Feb 3, 2016
Other
month 128 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)Feb 3, 2016
month 128 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)Feb 3, 2016
month 128 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)Feb 3, 2016
month 128 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)Feb 3, 2016
month 128 — 6× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sodium Acetate (Injection, Solution, Concentrate)

Labeler	Strength	First seen	Last seen
Hospira, Inc.	SODIUM ACETATE ANHYDROUS 164 mg/mL	Jul 15, 2026	Sep 3, 2026
Milla Pharmaceuticals Inc.	SODIUM ACETATE 164 mg/mL	Jul 15, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	SODIUM ACETATE 4 meq/100mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	SODIUM ACETATE ANHYDROUS 3.28 g/20mL	Jul 15, 2026	Aug 31, 2026
Amneal Pharmaceuticals Private Limited	SODIUM ACETATE ANHYDROUS 164 mg/mL	Jul 15, 2026	Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Acetate — NDC 80830-2435-02," retrieved September 3, 2026, https://drugdashboards.com/drug/80830243502.

Free to cite with attribution — see how the data is put together.